ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,204Medicare Part D Prescriptions Filled, Including Refills

Rank: 299 out of 2061

$740K Total Retail Price of All Prescriptions

Rank: 304 out of 2061

601 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 601 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 601 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 11,407 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 651 613 1 3
SIMVASTATIN 492 459 2 1
OMEPRAZOLE 454 435 3 5
LISINOPRIL 387 361 4 2
AMLODIPINE BESYLATE 378 373 5 4
PRAVASTATIN SODIUM 322 314 6 14
ATORVASTATIN CALCIUM 315 274 7 8
FUROSEMIDE 286 278 8 6
CRESTOR 284 270 9 31
METOPROLOL SUCCINATE 255 250 10 19
METOPROLOL TARTRATE 243 218 11 7
METFORMIN HCL 229 224 12 9
CLONIDINE HCL 182 182 13 52
ZOLPIDEM TARTRATE 178 177 14 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 157 139 15 27
CARVEDILOL 155 139 16 22
ALLOPURINOL 154 140 17 28
PANTOPRAZOLE SODIUM 150 144 18 45
ATENOLOL 144 141 19 13
KLOR-CON M20 134 130 20 47
HYDROCODONE-ACETAMINOPHEN 131 122 S3 21 10
ALENDRONATE SODIUM 125 123 22 25
SERTRALINE HCL 120 120 23 21
GLIMEPIRIDE 120 109 23 33
CLOPIDOGREL 120 115 23 29
LOSARTAN POTASSIUM 120 115 23 17
SPIRONOLACTONE 114 100 27 62
POTASSIUM CHLORIDE 113 103 28 16
LOSARTAN-HYDROCHLOROTHIAZIDE 111 111 29 50
NAMENDA 108 108 30 37
CITALOPRAM HBR 108 96 30 20
AZITHROMYCIN 107 99 32 34
GABAPENTIN 103 102 33 15
WARFARIN SODIUM 103 76 33 11
PLAVIX 98 98 35 49
LOVASTATIN 94 94 36 35
DONEPEZIL HCL 92 92 37 24
HYDROCHLOROTHIAZIDE 86 78 38 12
DIOVAN 78 67 39 41
LIPITOR 75 63 40 70
FLUTICASONE PROPIONATE 71 69 41 43
LABETALOL HCL 70 70 42 161
ATENOLOL-CHLORTHALIDONE 69 69 43 202
ISOSORBIDE MONONITRATE ER 67 67 44 42
JANUVIA 66 58 45 51
MIRTAZAPINE 63 63 46 46
SPIRONOLACTONE-HCTZ 63 48 46 222
TRAMADOL HCL 58 55 48 18
SYNTHROID 57 57 49 58
TRAZODONE HCL 56 45 50 39
TAMSULOSIN HCL 54 51 51 30
EXELON 53 53 52 94
DOXAZOSIN MESYLATE 52 52 53 81
CHLORTHALIDONE 52 51 53 165
TOPROL XL 51 46 55 169
NEXIUM 50 44 56 26
LANSOPRAZOLE 50 47 56 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.